Your browser is no longer supported. Please, upgrade your browser.
Settings
ACAD ACADIA Pharmaceuticals Inc. daily Stock Chart
ACAD [NASD]
ACADIA Pharmaceuticals Inc.
Index- P/E- EPS (ttm)-1.92 Insider Own0.20% Shs Outstand117.71M Perf Week-2.32%
Market Cap3.87B Forward P/E- EPS next Y-1.46 Insider Trans- Shs Float117.71M Perf Month-10.56%
Income-205.80M PEG- EPS next Q-0.55 Inst Own94.90% Short Float16.11% Perf Quarter-7.72%
Sales0.20M P/S19339.75 EPS this Y-71.80% Inst Trans0.83% Short Ratio8.35 Perf Half Y90.38%
Book/sh3.61 P/B9.10 EPS next Y32.10% ROA-60.00% Target Price46.13 Perf Year-13.32%
Cash/sh3.51 P/C9.37 EPS next 5Y9.50% ROE-64.20% 52W Range16.64 - 43.89 Perf YTD-7.83%
Dividend- P/FCF- EPS past 5Y-43.90% ROI- 52W High-25.13% Beta3.44
Dividend %- Quick Ratio14.50 Sales past 5Y- Gross Margin- 52W Low97.48% ATR1.60
Employees330 Current Ratio14.60 Sales Q/Q9600.00% Oper. Margin- RSI (14)45.97 Volatility4.85% 4.64%
OptionableYes Debt/Eq0.00 EPS Q/Q-60.40% Profit Margin- Rel Volume0.64 Prev Close32.30
ShortableYes LT Debt/Eq0.00 EarningsAug 04 AMC Payout- Avg Volume2.27M Price32.86
Recom2.10 SMA20-3.63% SMA50-4.01% SMA2007.88% Volume1,464,019 Change1.73%
Jun-22-16Downgrade BofA/Merrill Buy → Neutral
May-03-16Downgrade Leerink Partners Outperform → Mkt Perform
Mar-30-16Reiterated Piper Jaffray Overweight $39 → $44
Feb-08-16Initiated BofA/Merrill Buy $40
Jan-22-16Upgrade Piper Jaffray Neutral → Overweight
Aug-27-15Upgrade Piper Jaffray Neutral → Overweight $48
Aug-07-15Reiterated Needham Buy $38 → $49
Aug-07-15Downgrade Piper Jaffray Overweight → Neutral
Apr-16-15Initiated Leerink Partners Outperform $48
Mar-12-15Reiterated Needham Buy $40 → $38
Feb-24-15Initiated H.C. Wainwright Buy $50
Feb-06-15Resumed ROTH Capital Buy $42
Dec-22-14Reiterated Needham Buy $26 → $40
Aug-07-13Reiterated Needham Buy $16 → $26
Aug-07-13Reiterated Ladenburg Thalmann Buy $15 → $24
Aug-07-13Downgrade MLV & Co Buy → Hold $18 → $20
Apr-11-13Reiterated Needham Buy $9 → $16
Apr-11-13Reiterated MLV & Co Buy $12.50 → $18
Apr-11-13Reiterated Ladenburg Thalmann Buy $9 → $15
Mar-13-13Reiterated Ladenburg Thalmann Buy $8 → $9
Aug-28-16 06:41AM  3 Stocks Up Over 1,000% in the Past 5 Years at Motley Fool
Aug-25-16 08:05AM  ACADIA Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : ACAD-US : August 25, 2016
07:18AM  CFO Moves: Acadia Pharmaceuticals, Liberty Global at The Wall Street Journal
Aug-24-16 04:23PM  ACADIA PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers -5.53%
09:00AM  ACADIA Pharmaceuticals Announces Appointment of Todd S. Young as Executive Vice President, Chief Financial Officer Business Wire
Aug-23-16 04:40PM  ACADIA Pharmaceuticals Announces Full Exercise of Underwriters Option to Purchase Additional Shares Business Wire
03:41PM  3 Biotech Stocks With Explosive Upside Potential at Motley Fool
Aug-22-16 10:59AM  ETFs with exposure to ACADIA Pharmaceuticals, Inc. : August 22, 2016
Aug-15-16 10:01AM  Acadia Pharmaceuticals (ACAD): Baker Bros. Advisors Buys More Shares at Insider Monkey
Aug-12-16 01:04PM  ACADIA PHARMACEUTICALS INC Financials
Aug-11-16 09:05AM  5 Can't-Miss Quotes From ACADIA Pharmaceuticals Inc.'s Q2 Investor Call at Motley Fool
Aug-10-16 04:51PM  ACADIA PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits -6.78%
03:29PM  ETFs with exposure to ACADIA Pharmaceuticals, Inc. : August 10, 2016
11:01AM  ACADIA Pharmaceuticals, Inc. :ACAD-US: Earnings Analysis: Q2, 2016 By the Numbers : August 10, 2016
Aug-09-16 08:50PM  ACADIA Pharmaceuticals Prices Public Offering of Common Stock Business Wire -5.36%
08:22AM  ACADIA Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : ACAD-US : August 9, 2016
Aug-08-16 04:01PM  ACADIA Pharmaceuticals Announces Proposed Public Offering of Common Stock Business Wire
Aug-05-16 04:13PM  Edited Transcript of ACAD earnings conference call or presentation 4-Aug-16 9:00pm GMT
12:42PM  Why 2U, Take-Two, Acadia, Air Lease and Acxiom Are Making Headlines Today at Insider Monkey
Aug-04-16 07:01PM  Acadia reports 2Q loss
05:00PM  ACADIA Pharmaceuticals Inc Earnings Call scheduled for 5:00 pm ET today
04:14PM  ACADIA PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an
04:05PM  ACADIA Pharmaceuticals Reports Second Quarter 2016 Financial Results Business Wire
07:07AM  Q2 2016 ACADIA Pharmaceuticals Inc Earnings Release - After Market Close
Aug-03-16 09:36AM  5 Drug Stocks to Watch for Earnings on Aug 4: BMRN & More
Aug-02-16 07:54AM  ACADIA (ACAD) Q2 Earnings: What's in Store for the Stock?
Jul-29-16 06:15PM  ACADIA Pharmaceuticals to Announce Second Quarter 2016 Financial Results on August 4, 2016 Business Wire
Jul-26-16 12:38PM  ETFs with exposure to ACADIA Pharmaceuticals, Inc. : July 26, 2016
Jul-23-16 10:41AM  These 3 Biotechs Have Automatic Demand at Motley Fool
Jul-22-16 08:08AM  ACADIA Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : ACAD-US : July 22, 2016
Jul-18-16 01:03PM  This Could Be the Next Big Pharma Buyout at Motley Fool
Jul-12-16 04:25PM  3 Risky Biotech Stocks That Could Make You Rich at Motley Fool
Jul-05-16 11:56AM  ACADIA Pharmaceuticals, Inc. Value Analysis (NASDAQ:ACAD) : July 5, 2016
08:22AM  These 3 Biotech Stocks Are Ridiculously Cheap Now at Motley Fool
Jul-04-16 08:20AM  ACADIA Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : ACAD-US : July 4, 2016
Jul-01-16 04:22PM  These were The Top 10 Trending Stocks This Week +5.51%
08:23AM  Merger and Acquisition Activity in the Biotech Sector Potentially on the Rise after Pfizers $5.2 Billion Purchase
Jun-30-16 03:32PM  ETFs with exposure to ACADIA Pharmaceuticals, Inc. : June 30, 2016
09:09AM  Merger and Acquisition Activity in the Biotech Sector Potentially on the Rise after Pfizers $5.2 Billion Purchase
09:09AM  Merger and Acquisition Activity in the Biotech Sector Potentially on the Rise after Pfizers $5.2 Billion Purchase Company Spotlight
Jun-28-16 12:24PM  ACADIA Pharmaceuticals Inc.'s Shareholders Are Having a Crazy Year. Here's Why at Motley Fool
Jun-27-16 09:00AM  ACADIA Pharmaceuticals Added to Large-Cap Russell 1000 Market Index Business Wire
Jun-22-16 08:07AM  Analysts' Actions -- Domino's, McDonald's, Priceline, Tesla and More
07:16AM  ACADIA Pharmaceuticals downgraded by BofA/Merrill
Jun-21-16 12:32PM  S&P 500s technical backdrop remains bullish-leaning pending Brexit vote at MarketWatch -6.44%
Jun-17-16 07:16AM  Limited upside seen for Acadia Pharma
Jun-16-16 09:05AM  Analyzing IBBs Moving Averages
09:00AM  ACADIA Pharmaceuticals to Present at the JMP Securities Life Sciences Conference on June 21, 2016 Business Wire
Jun-12-16 06:43AM  Is Acadia Pharmaceuticals' Stock Still a Buy? at Motley Fool
Jun-10-16 05:10PM  ACADIA PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a
Jun-08-16 02:09PM  ETFs with exposure to ACADIA Pharmaceuticals, Inc. : June 8, 2016
Jun-06-16 04:30PM  Why Shares of ACADIA Pharmaceuticals Inc. Jumped Today at Motley Fool +12.78%
Jun-01-16 09:00AM  ACADIA Pharmaceuticals to Present at the Goldman Sachs 37th Annual Global Healthcare Conference on June 8, 2016 Business Wire
May-31-16 05:58PM  What Happened to Ioniss Revenues in 1Q16?
08:00AM  ACADIA Pharmaceuticals Announces NUPLAZID (pimavanserin) Is Now Available for the Treatment of Hallucinations and Delusions Associated with Parkinsons Disease Psychosis Business Wire
May-27-16 08:33AM  Delayed FDA Decision Sends Sarepta Therapeutics Soaring
May-26-16 06:00AM  'Mad Money' Lightning Round: I'm Buying Buffett's Berkshire Hathaway
May-25-16 09:07AM  XBIs and IHIs Mid-Caps Soared, Overturning 2 Weeks of Losses
May-20-16 09:06AM  Pfizer, Biogen Can Fancy Acadia for Takeover
May-18-16 10:16PM  ETFs with exposure to ACADIA Pharmaceuticals, Inc. : May 19, 2016
May-17-16 01:45PM  ACADIA Pharmaceuticals, Inc. :ACAD-US: Earnings Analysis: Q1, 2016 By the Numbers +5.59%
May-16-16 09:00AM  Sarepta's AdCom Needs FDA's Permission To Speak Freely at Forbes +6.83%
May-11-16 07:00PM  Cramer: I suspect this stock is a classic value trap at CNBC
May-10-16 07:45AM  Merrill Lynch Has 3 Top BioPharma Picks to Win From the Aging of America at 24/7 Wall St.
May-09-16 02:00PM  Acadia Pharmaceutical's Nuplazid Pricing Is Good News for Shareholders at TheStreet +5.79%
May-06-16 01:05PM  Edited Transcript of ACAD earnings conference call or presentation 5-May-16 9:00pm GMT
May-05-16 05:44PM  Acadia reports 1Q loss
05:02PM  Acadia (ACAD) Stock Slides in After-Hours Trading on Q1 Financial Results at TheStreet
05:00PM  ACADIA Pharmaceuticals Inc Earnings Call scheduled for 5:00 pm ET today CCBN
04:18PM  ACADIA PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an EDGAR Online
04:05PM  ACADIA Pharmaceuticals Reports First Quarter 2016 Financial Results Business Wire
11:22AM  Acadia Drug Approval May Entice Biogen, Teva as Buyers The Deal Pipeline
07:07AM  Q1 2016 ACADIA Pharmaceuticals Inc Earnings Release - After Market Close CCBN
May-04-16 02:17PM  Acadia Pharmaceuticals Stock Has Fallen Too Far Recently at TheStreet -8.23%
09:01AM  ACADIA Pharmaceuticals to Present at the Bank of America Merrill Lynch 2016 Health Care Conference on May 11, 2016 Business Wire
08:22AM  Why ACADIA Pharmaceuticals Inc Jumped 12.7% in April at Motley Fool
May-03-16 04:43PM  ACADIA PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial Sta EDGAR Online -9.09%
01:50PM  Put the trade on......NOW Yahoo Finance Contributors
10:03AM  Why Acadia Pharma's First Drug Approval Isn't Moving Stock Higher at TheStreet
08:22AM  8 Stocks Spiking on Big Volume at TheStreet
08:12AM  Analysts' Actions -- Amazon, Walmart, Acadia, International Paper and More TheStreet
May-02-16 04:14PM  Investors Await Pricing of Acadia's Recently Approved Parkinson's Drug at TheStreet
04:01PM  ACADIA Pharmaceuticals to Announce First Quarter 2016 Financial Results on May 5, 2016 Business Wire
02:08PM  FDA approves drug to treat highly disruptive symptom of Parkinsons disease at MarketWatch
11:34AM  ACADIA Pharmaceuticals (ACAD) Stock Down Despite Nuplazid Approval at TheStreet
11:10AM  An antidote to trading on tilt Yahoo Finance Contributors
08:38AM  A drug that could change the way we treat Parkinson's disease just got approved Business Insider
08:30AM  ACADIA Pharmaceuticals Inc to discuss the FDA approval of NUPLAZID Call scheduled for 8:30 am ET today CCBN
02:16AM  Trending Now: ACAD Yahoo Finance - Qwiki
Apr-30-16 08:02AM  3 All-or-Nothing Stocks To Watch Closely at Motley Fool
Apr-29-16 07:17PM  FDA Approves ACADIA Pharmaceuticals NUPLAZID (pimavanserin) - The First Drug Approved for the Treatment of Hallucinations and Delusions Associated with Parkinsons Disease Psychosis Business Wire
06:26PM  U.S. approves first drug for psychosis linked to Parkinson's Reuters
05:55PM  First drug for delusions in Parkinson's patients approved AP
05:38PM  U.S. approves Acadia drug for Parkinson's disease-linked psychosis Reuters
Apr-28-16 12:59PM  Acadia drug approval could clear way for Axovant dementia therapy Reuters
Apr-25-16 08:14AM  Acadia Pharma faces downside position optionMONSTER
Apr-23-16 03:00PM  Billionaires Love These 3 Stocks -- But Are They Right for You? at Motley Fool
Apr-18-16 09:41AM  3 Stocks That Could Double Your Money at Motley Fool
Apr-10-16 10:05AM  Massive Biotech Insider Buy Highlights Volatile Trading Week: Acadia, Conns, William Lyon, Summit Midstream and More at 24/7 Wall St.
Apr-09-16 10:00AM  3 Stocks the Smartest Investors Are Buying Now at Motley Fool
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. Its lead product candidate, NUPLAZID, has completed the Phase III pivotal trials for the treatment of Parkinson's disease psychosis and the Phase II trial for the treatment of schizophrenia, as well as is in Phase II study for the treatment of Alzheimer's disease psychosis. It also has clinical-stage programs for glaucoma and, in collaboration with Allergan, Inc., for chronic pain. ACADIA Pharmaceuticals Inc. was founded in 1993 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HARRIGAN EDMUNDDirectorAug 16Buy32.971,00032,9701,000Aug 18 05:14 PM
BAKER BROS. ADVISORS LPDirectorAug 10Buy33.001,303,03042,999,99022,337,275Aug 12 04:08 PM
Baity GlennEVP AND GCJul 12Option Exercise6.7811,94380,97474,864Jul 13 06:28 PM
Baity GlennEVP AND GCJul 12Sale35.0011,943418,03162,921Jul 13 06:28 PM
Baity GlennEVP AND GCJul 11Option Exercise6.784,05727,50666,978Jul 13 06:28 PM
Baity GlennEVP AND GCJul 11Sale35.004,057142,00162,921Jul 13 06:28 PM
GRAY MARY ANNDirectorJun 07Option Exercise9.0416,637150,398149,476Jun 09 05:28 PM
Iversen Leslie LDirectorApr 18Option Exercise1.7533,69758,97069,824Apr 20 05:37 PM
Iversen Leslie LDirectorApr 18Sale33.5333,6971,129,99936,127Apr 20 05:37 PM
GRAY MARY ANNDirectorApr 07Option Exercise1.33132,839176,600132,839Apr 07 08:27 PM
BAKER BROS. ADVISORS LPDirectorApr 01Buy28.52302,9008,638,57221,167,398Apr 01 04:21 PM
BAKER BROS. ADVISORS LPDirectorMar 31Buy27.21683,64418,601,18020,894,327Apr 01 04:21 PM
BAKER BROS. ADVISORS LPDirectorMar 30Buy25.94462,54612,000,0562,799,646Apr 01 04:21 PM
Baity GlennEVP AND GCMar 02Option Exercise15.377,000107,59069,921Mar 04 04:54 PM
Baity GlennEVP AND GCMar 02Sale20.807,000145,58062,921Mar 04 04:54 PM
14159, L.P.DirectorJan 07Buy29.002,586,20674,999,97420,278,008Jan 08 06:07 PM
Iversen Leslie LDirectorNov 11Option Exercise7.8630,000235,66966,127Nov 13 05:45 PM
Iversen Leslie LDirectorNov 11Sale36.0130,0001,080,32736,127Nov 13 05:45 PM